Market Synopsis
The biobanking market was valued at USD 950 million in 2017 and is expected to register a CAGR of 7.6% during the forecast period. The global biobanking market is majorly driven by the increasing applications in life sciences, increasing technical advanced devices, increasing demand for research activities in genomics for studying various diseases, and growing penetration by market players. Additionally, factors such as increasing government and private funding to support the regenerative medicine research are likely to boost the market growth during the forecast period.
also read @ https://www.openpr.com/news/2212583/biobanking-market-size-will-grow-at-a-cagr-of-7-6-by-2023
Biobanking Market Segmentation
The global biobanking market is segmented by products and services, sample type, storage type, application, and end-user.
On the basis of products and services, the biobanking market is segmented into equipment, services, consumables, and software. Equipment is further sub-segmented into sample transport equipment, sample processing equipment, storage equipment, sample analysis equipment, and others. Consumables are further sub-segmented into processing consumables, storage consumables, analysis consumables, collection consumables, and others. Services are sub-segmented into processing services, storage services, transport services, and supply services.
By sample type, the biobanking market is segmented into biological fluids, blood products, cell lines, human tissues, nucleic acids, and others.
Based on storage type the biobanking market is segmented into manual storage and automated storage. Applications of the market include life science research, regenerative medicine, and clinical research.
By end-user, the biobanking market is segmented into research centers, hospitals, diagnostic laboratory, and others.
Biobanking Market Regional Analysis
Based on region the biobanking market is segmented into Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA). The Americas region is segmented into North America and South America.
The Americas is the largest biobanking market due to heavy investments in research of theranostics and a large patient pool suffering from chronic diseases. Presence of large number of biobanks in hospitals in the U.S. can encourage growth in North America. On the other hand, South America can grow at a rapid pace due to increasing demand for advanced treatments for chronic diseases and technologically advanced diagnostic devices.
Europe can also exhibit a stellar growth rate during the forecast period due to emphasis on research and development activities in diagnosis and treatment of diseases. Collaboration between biobanks and pharmaceutical companies for encouraging research can drive the global biobanking market growth. On the other hand, APAC can be lucrative for the global biobanking market due to inclination towards drug discovery and scientific research.
Biobanking Market Competition Outlook
Tecan Trading AG, Qiagen N.V., Brooks Automation, Inc., VWR Corporation, Becton, Dickinson and Company, Promega Corporation, Hamilton Company, Panasonic Healthcare Holdings Co., Ltd., Greiner Holding AG, Thermo Fisher Scientific Inc., Chart Industries, Inc., Merck KGaA, and others are notable players of the global biobanking market.
Browse More Details at: https://www.marketresearchfuture.com/reports/biobanking-market-5967
Biobanking Industry News
The Manchester Cancer Research Center biobank collects ovarian cysts samples from women afflicted with the disease. This sample can be used in the testing of new drugs and its efficacy for its future commercialization.
RELATED REPORTS
Global Wound Closure Device Market Research Report- Forecast to 2027
Contraceptive Pills Market Research Report- Global Forecast To 2027
Dermatology Diagnostic device Market Research Report- Global Forecast To 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
